Great success in Boston Massachusetts at the research center. By Dr. Héctor Damián Brzostowski, update 12/12/2021, EBF technology clinic.
Great success in Boston Massachusetts at the research center. By Dr. Héctor Damián Brzostowski, update 12/12/2021, EBF technology clinic.
As a scientist and our team we have developed a new approach to harness the pro-inflammatory properties of IL-12 and reduce its associated adverse effects. Find out how IL-12 was designed to support preferential signaling within the tumor microenvironment, helping to activate innate and adaptive immune responses.
Our Recombinant Stem Cells EBF Technology EIRELI has been applying it for 15 years helping our partners and patients.
https://m.facebook.com/story.php?story_fbid=6049120121765889&id=100000038847895
Comentarios
Publicar un comentario